Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate efficacy study for uncomplicated malaria in Myanmar
ACTRN12614000215628Phase 3Recruiting
- Sponsor
- Defense Services General Hospital
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of artesunate in malaria and Malaria, sponsored by Defense Services General Hospital. Primary endpoints: Early treatment failure, Late treatment failure and 2 more. Started Jan 2014; status: recruiting.
02
Drugs
artesunate
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12614000215628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000215628.